Skip to main content

Krystal Biotech, Inc.

KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711279

In the last 90 days, Krystal Biotech, Inc. insiders filed 0 open-market purchases and 3 sales; 422 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Krystal Biotech, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
137
+4 vs. Q1 2022
Shares held
20.8M
+228.8K (+1.1%) vs. Q1 2022
Total value
$1.36B
−$1.46M (−0.1%) vs. Q1 2022
New holders
19
46 more added
Sold out
15
52 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KRYS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 137 institutions
Q1 2021: 113 institutionsQ2 2021: 113 institutionsQ3 2021: 113 institutionsQ4 2021: 140 institutionsQ1 2022: 135 institutionsQ2 2022: 137 institutionsQ3 2022: 148 institutionsQ4 2022: 154 institutionsQ1 2023: 160 institutionsQ2 2023: 183 institutionsQ3 2023: 188 institutionsQ4 2023: 194 institutionsQ1 2024: 234 institutionsQ2 2024: 245 institutionsQ3 2024: 283 institutionsQ4 2024: 264 institutionsQ1 2025: 299 institutionsQ2 2025: 275 institutionsQ3 2025: 284 institutionsQ4 2025: 334 institutionsQ1 2026: 368 institutionsQ2 2026: 422 institutions
Value heldQ2 2022: $1.36B
Q1 2021: $1.27BQ2 2021: $1.12BQ3 2021: $850.7MQ4 2021: $1.35BQ1 2022: $1.37BQ2 2022: $1.36BQ3 2022: $1.45BQ4 2022: $1.66BQ1 2023: $1.68BQ2 2023: $2.71BQ3 2023: $2.76BQ4 2023: $3.03BQ1 2024: $4.49BQ2 2024: $5.24BQ3 2024: $5.15BQ4 2024: $4.35BQ1 2025: $4.98BQ2 2025: $3.80BQ3 2025: $4.94BQ4 2025: $7.01BQ1 2026: $7.32BQ2 2026: $11.1B
Institutions holding KRYS and their total value by quarter
QuarterHoldersValue
Q2 2026422$11.1B
Q1 2026368$7.32B
Q4 2025334$7.01B
Q3 2025284$4.94B
Q2 2025275$3.80B
Q1 2025299$4.98B
Q4 2024264$4.35B
Q3 2024283$5.15B
Q2 2024245$5.24B
Q1 2024234$4.49B
Q4 2023194$3.03B
Q3 2023188$2.76B
Q2 2023183$2.71B
Q1 2023160$1.68B
Q4 2022154$1.66B
Q3 2022148$1.45B
Q2 2022137$1.36B
Q1 2022135$1.37B
Q4 2021140$1.35B
Q3 2021113$850.7M
Q2 2021113$1.12B
Q1 2021113$1.27B

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Krystal Biotech, Inc.; share changes are against Q1 2022.

Institutions holding KRYS in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
CWM, LLC45,144$2.96M0.02%−7,159−13.7%Reduced
Integral Health Asset Management, LLC52,184$3.43M0.70%+52,184New
Verition Fund Management LLC54,744$3.59M0.08%+23,578+75.7%Added
Allianz Asset Management GmbH57,689$3.79M0.00%+27,809+93.1%Added
ACT Capital Management, LLC59,000$3.87M5.42%00.0%Unchanged
Morgan Stanley79,354$5.21M0.00%+7,374+10.2%Added
Bank of New York Mellon Corp80,263$5.27M0.00%−6,632−7.6%Reduced
Nuveen Asset Management, LLC85,356$5.60M0.00%+1,097+1.3%Added
Rubric Capital Management LP92,609$6.08M0.32%+92,609New
Silverarc Capital Management, LLC105,277$6.91M3.24%+58,788+126.5%Added
S Squared Technology, LLC108,215$7.11M4.92%00.0%Unchanged
Handelsbanken Fonder AB112,900$7.41M0.05%+2,900+2.6%Added
Charles Schwab Investment Management Inc148,752$9.77M0.00%+405+0.3%Added
Goldman Sachs Group Inc163,744$10.8M0.00%+27,697+20.4%Added
Northern Trust Corp201,058$13.2M0.00%+6,956+3.6%Added
Soleus Capital Management, L.P.214,482$14.1M2.26%−74,855−25.9%Reduced
C WorldWide Group Holding A/S225,809$14.8M0.19%00.0%Unchanged
Nicholas Investment Partners, LP227,877$15.0M1.41%−855−0.4%Reduced
JPMorgan Chase & Co258,567$17.0M0.00%+706+0.3%Added
Dimensional Fund Advisors LP275,923$18.1M0.01%+13,460+5.1%Added
Skandinaviska Enskilda Banken AB (publ)297,610$19.5M0.14%+88,899+42.6%Added
Geode Capital Management, LLC385,375$25.3M0.00%+20,085+5.5%Added
Hood River Capital Management LLC409,011$26.9M1.07%+24,201+6.3%Added
Artal Group S.A.500,000$32.8M1.83%00.0%Unchanged
First Light Asset Management, LLC595,612$39.1M4.55%−122,324−17.0%Reduced
Credit Suisse AG702,903$46.2M0.05%−54,956−7.3%Reduced
Pictet Asset Management SA745,106$48.9M0.07%+56,551+8.2%Added
Baker Bros. Advisors LP807,735$53.0M0.30%00.0%Unchanged
State Street Corp1,036,041$68.0M0.00%−32,615−3.1%Reduced
Vanguard Group Inc1,069,288$70.2M0.00%+17,843+1.7%Added
Avoro Capital Advisors LLC1,075,000$70.6M1.39%+70,000+7.0%Added
Frazier Life Sciences Management, L.P.1,095,407$71.9M6.79%+229,157+26.5%Added
Lord, Abbett & Co. LLC1,117,566$73.4M0.26%−61,247−5.2%Reduced
Point72 Asset Management, L.P.1,574,275$103.4M0.49%−145,992−8.5%Reduced
BlackRock Inc.1,701,322$111.7M0.00%+17,811+1.1%Added
Redmile Group, LLC1,898,545$124.7M4.76%+82,847+4.6%Added
FMR LLC2,106,256$138.3M0.01%−2360.0%Reduced
Jennison Associates LLC0$00.00%−68,309−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−25,310−100.0%Sold out
DnB Asset Management AS0$00.00%−24,500−100.0%Sold out
Kynam Capital Management, LP0$00.00%−18,393−100.0%Sold out
Citadel Advisors LLC0$00.00%−8,732−100.0%Sold out
NinePointTwo Capital0$00.00%−6,186−100.0%Sold out
Merriman Wealth Management, LLC0$00.00%−5,000−100.0%Sold out
Janus Henderson Group PLC0$00.00%−4,304−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−3,584−100.0%Sold out
DuPont Capital Management Corp0$00.00%−2,319−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−100−100.0%Sold out
Money Concepts Capital Corp0$00.00%−55−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−28−100.0%Sold out
Simplex Trading, LLC0$00.00%−26−100.0%Sold out
TCWP LLC0$00.00%−7−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed